Arecor Announces Transfer Of Novel Therapeutic Product To Hikma
FTSE 250 company Hikma have triggered the transfer of Arecors’s AT307 product including a milestone payment.
Calculus Capital is a pioneer of tax efficient investing, having launched the UK’s first approved EIS Fund in 1999. We offer an opportunity to invest in a portfolio of entrepreneurial UK growth businesses, through our award winning Calculus EIS Funds and Calculus VCT. We invest in the fastest growing sectors of the UK economy – technology, healthcare and creative industries.
Learn about the tax-efficient investment opportunities offered by our Calculus EIS Fund and Calculus VCT
We would be delighted to learn about your business and discuss whether Calculus could be a suitable investment partner
FTSE 250 company Hikma have triggered the transfer of Arecors’s AT307 product including a milestone payment.
Calculus CEO, John Glencross, gives an update on the happenings in Q4 2022.
Home Team will develop and produce premium television projects with UIS for the UK and global market
C4X Discovery continues its progress with the signing of an exclusive global license with AstraZeneca.